3D Systems

DDD · NYSE

$2.98+$0.09 (+3.11%)TodayMarket closed ·
Prev close $2.89

DDD analyst rating

BuyConsensus of 1 analyst over the last 12 months. 100% rate it a buy.
  • Strong buy0
  • Buy1
  • Hold0
  • Underperform0
  • Sell0

12-month price target · 3 analysts

Average $5.61 (+88.3% upside)

Low
$5.05
Now
$2.98
High
$6.30

Upgrades and downgrades

The latest rating actions, newest first

DDD analyst upgrades, downgrades and rating actions
FirmDateActionRating
Cantor FitzgeraldMay 13, 2026MaintainsOverweight
Cantor FitzgeraldNov 6, 2025MaintainsOverweight

The case for and against

Updated Oct 31, 2025

Bull case

3D Systems Corp has demonstrated a strategic focus on organic growth while reinforcing its position through several small acquisitions in both the healthcare and industrial markets. Notably, the Personalized Healthcare business experienced a 17% year-over-year growth, alongside an 18% increase in FDA-approved parts manufacturing, suggesting a robust demand in these segments. Additionally, the company achieved a $5 million year-over-year improvement in operating expenses, reflecting increased operational efficiency that could positively impact profitability.

Bear case

3D Systems Corp reported a significant decline in revenues, with Q1 revenues decreasing by 8% year-over-year to $94.5 million, which fell short of market expectations that anticipated a smaller decline of 3%. The Industrial segment, comprising approximately 56% of total Q1 revenues, experienced a 7% decline from the prior quarter, attributed to customers delaying investments amid a challenging macroeconomic climate. Additionally, the company's materials sales plummeted by 23% year-over-year due to inventory management issues in the dental aligner market and diminished sales in other markets, overshadowing growth in new hardware systems and related services.

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.